US 12,006,318 B2Granted

Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof

AssigneeRapt Therapeutics, Inc.

InventorsDavid J. Arnold, Omar Robles, Duane E. Rudisill, David J. Wustrow, Mikhail Zibinsky, Sami Karaborni

Life of this patent

Estimating the term…

Abstract

Crystalline forms of a C-C chemokine receptor type 4 (CCR4) antagonist, oral dosage forms of same and methods of using and preparing same, are provided.

Claims46

Dependent claims

Compound 2-((R)-3-(1-(1-((R)-1-(2,4-Dichlorophenyl)ethyl)-3-(trifluoromethyl)-1H-pyrazolo[3,4-13]pyrazin-6-yl)azetidin-3-yl)piperidin-1-yl)ethan-1-ol benzene sulfonate in crystalline form.

Dependencies are inferred from the claim text.

Facts

Application: 17/098,157Filed 13 Nov 2020 · us provisional application
Priority: 13 Nov 2019
Published: US 2021/0139487 A113 May 2021
Granted: 11 Jun 2024
Term ends: Not estimatedThe source records don’t support an estimate.

Classification15 codes

C07D 487/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/2018
Organic compounds, e.g. phospholipids, fats: sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
A61K 9/2054
Polysaccharides, e.g. alginate, gums; Cyclodextrin: cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Family

Application62/935,007Us provisional application · filed 13 Nov 2019
US 2021/0139487 A1Pre-grant publication · published 13 May 2021
US 12,006,318 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results